Oculis Holding AG (OCS) Change in Account Payables (2022 - 2024)

Oculis Holding AG's (OCS) quarterly Change in Account Payables came in at $2.5 million in Q4 2024, up 188.29% year-on-year from $851726.4 in Q1 2024, and up 23.68% quarter-over-quarter from $2.0 million in Q3 2024.

Oculis Holding AG (OCS) Change in Account Payables (2022 - 2024) Analysis & Trends

Oculis Holding AG's Change in Account Payables history runs 3 years deep, the most recent figure standing at $2.5 million for Q4 2024.

  • On a quarterly basis, Change in Account Payables rose 188.29% year-over-year to $2.5 million in Q4 2024; TTM through Dec 2024 was -$514032.6, a 200.93% decrease from a year earlier, with the FY2024 full-year figure at -$429673.2, down 202.09% from the prior year.
  • Change in Account Payables grew to $2.5 million in Q4 2024 per OCS's latest filing, from $2.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $3.5 million in Q4 2022 and bottomed at -$7.4 million in Q1 2024.
  • The 3-year median for Change in Account Payables is $2.1 million (2023), against an average of $266803.2.
  • Across the five-year window, Change in Account Payables jumped 527.44% in 2023 and plunged 215.5% in 2024, its largest moves.
  • Year by year, Change in Account Payables stood at $3.5 million in 2022, then plunged by 180.36% to -$2.8 million in 2023, then soared by 188.29% to $2.5 million in 2024.
  • Per Business Quant, the three latest OCS Change in Account Payables figures stand at $2.5 million (Q4 2024), $2.0 million (Q3 2024), and $2.4 million (Q2 2024).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -42.19 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.52 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.86 Mn
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.46 Mn
Dec 31, 2024 2.46 Mn
Sep 30, 2024 1.99 Mn
Sep 30, 2024 1.99 Mn
Jun 30, 2024 2.40 Mn
Jun 30, 2024 2.40 Mn
Mar 31, 2024 -7.36 Mn
Mar 31, 2024 -7.36 Mn
Dec 31, 2023 -2.78 Mn
Dec 31, 2023 -2.78 Mn
Sep 30, 2023 3.37 Mn
Sep 30, 2023 3.37 Mn
Jun 30, 2023 2.25 Mn
Jun 30, 2023 2.25 Mn
Mar 31, 2023 -2.33 Mn
Mar 31, 2023 -2.33 Mn
Dec 31, 2022 3.46 Mn
Dec 31, 2022 3.46 Mn
Sep 30, 2022 -787,982.50
Sep 30, 2022 -787,982.50